BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1912 related articles for article (PubMed ID: 29652832)

  • 1. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
    Bellinger DL; Lorton D
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential use of drugs that target neural-immune pathways in the treatment of rheumatoid arthritis and other autoimmune diseases.
    Lorton D; Lubahn C; Bellinger DL
    Curr Drug Targets Inflamm Allergy; 2003 Mar; 2(1):1-30. PubMed ID: 14561173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system.
    Elenkov IJ; Wilder RL; Chrousos GP; Vizi ES
    Pharmacol Rev; 2000 Dec; 52(4):595-638. PubMed ID: 11121511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms underlying β-adrenergic receptor-mediated cross-talk between sympathetic neurons and immune cells.
    Lorton D; Bellinger DL
    Int J Mol Sci; 2015 Mar; 16(3):5635-65. PubMed ID: 25768345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Interplay between Autonomic Nervous System and Inflammation across Systemic Autoimmune Diseases.
    Bellocchi C; Carandina A; Montinaro B; Targetti E; Furlan L; Rodrigues GD; Tobaldini E; Montano N
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of
    Devaprasad A; Radstake TRDJ; Pandit A
    Front Immunol; 2021; 12():669400. PubMed ID: 34108969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases.
    Bunte K; Beikler T
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine metabolome profiling of immune-mediated inflammatory diseases.
    Alonso A; Julià A; Vinaixa M; Domènech E; Fernández-Nebro A; Cañete JD; Ferrándiz C; Tornero J; Gisbert JP; Nos P; Casbas AG; Puig L; González-Álvaro I; Pinto-Tasende JA; Blanco R; Rodríguez MA; Beltran A; Correig X; Marsal S;
    BMC Med; 2016 Sep; 14(1):133. PubMed ID: 27609333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases.
    Blandizzi C; Gionchetti P; Armuzzi A; Caporali R; Chimenti S; Cimaz R; Cimino L; Lapadula G; Lionetti P; Marchesoni A; Marcellusi A; Mennini FS; Salvarani C; Girolomoni G
    Int J Immunopathol Pharmacol; 2014; 27(1 Suppl):1-10. PubMed ID: 24774503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate lymphoid cells in autoimmunity and chronic inflammatory diseases.
    Xiong T; Turner JE
    Semin Immunopathol; 2018 Jul; 40(4):393-406. PubMed ID: 29568972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal-fetal outcomes in patients with immune-mediated inflammatory diseases, with consideration of comorbidities: a retrospective cohort study in a large U.S. healthcare system.
    Hwang YM; Wei Q; Piekos SN; Vemuri B; Molani S; Mease P; Hood L; Hadlock J
    EClinicalMedicine; 2024 Feb; 68():102435. PubMed ID: 38586478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.
    Antonioli L; Blandizzi C; Pacher P; Haskó G
    Pharmacol Rev; 2019 Jul; 71(3):345-382. PubMed ID: 31235653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study.
    Aletaha D; Epstein AJ; Skup M; Zueger P; Garg V; Panaccione R
    Adv Ther; 2019 Jul; 36(7):1672-1683. PubMed ID: 31102202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of the sympathetic nervous system in chronic inflammation].
    Pongratz G; Straub RH
    Z Rheumatol; 2023 Aug; 82(6):451-461. PubMed ID: 37488245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune-Mediated Inflammatory Diseases and accompanying comorbidities].
    Majdan M
    Wiad Lek; 2016; 69(4):611-615. PubMed ID: 27941197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing epidemiology of immune-mediated inflammatory diseases in immigrants: A systematic review of population-based studies.
    Agrawal M; Shah S; Patel A; Pinotti R; Colombel JF; Burisch J
    J Autoimmun; 2019 Dec; 105():102303. PubMed ID: 31351784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis.
    Koopman FA; van Maanen MA; Vervoordeldonk MJ; Tak PP
    J Intern Med; 2017 Jul; 282(1):64-75. PubMed ID: 28547815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomic regulation of cellular immune function.
    Bellinger DL; Lorton D
    Auton Neurosci; 2014 May; 182():15-41. PubMed ID: 24685093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
    Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal-fetal outcomes in patients with immune mediated inflammatory diseases, with consideration of comorbidities: a retrospective cohort study in a large U.S. healthcare system.
    Hwang YM; Wei Q; Piekos SN; Vemuri B; Molani S; Mease P; Hood L; Hadlock JJ
    medRxiv; 2023 Aug; ():. PubMed ID: 37609126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 96.